Musculoskeletal interventional oncology: current and future practices

Br J Radiol. 2020 Nov 1;93(1115):20200465. doi: 10.1259/bjr.20200465. Epub 2020 Aug 12.

Abstract

Management of musculoskeletal (MSK) tumours has traditionally been delivered by surgeons and medical oncologists. However, in recent years, image-guided interventional oncology (IO) has significantly impacted the clinical management of MSK tumours. With the rapid evolution of relevant technologies and the expanding range of clinical indications, it is likely that the impact of IO will significantly grow and further evolve in the near future.In this narrative review, we describe well-established and new interventional technologies that are currently integrating into the IO armamentarium available to radiologists to treat MSK tumours and illustrate new emerging IO indications for treatment.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Bone Neoplasms / therapy*
  • Cancer Pain / therapy
  • Combined Modality Therapy / methods
  • Cryosurgery / methods
  • Electroporation / methods
  • Evoked Potentials
  • Female
  • Fluoroscopy / methods
  • Forecasting
  • Fractures, Bone / therapy
  • High-Intensity Focused Ultrasound Ablation
  • Humans
  • Iatrogenic Disease / prevention & control
  • Liposomes / administration & dosage
  • Magnetic Resonance Imaging, Interventional / methods
  • Male
  • Medical Oncology / trends*
  • Microwaves / therapeutic use
  • Muscle Neoplasms / therapy*
  • Peripheral Nerve Injuries / etiology
  • Peripheral Nerve Injuries / prevention & control
  • Radiofrequency Ablation / methods
  • Radiofrequency Therapy / methods
  • Radiology, Interventional / methods
  • Radiology, Interventional / trends
  • Spinal Neoplasms / therapy
  • Spine / surgery
  • Tomography, X-Ray Computed / methods
  • Ultrasonography, Interventional / methods

Substances

  • Antineoplastic Agents
  • Liposomes